NCT00530205

Brief Summary

RATIONALE: Learning about the effects of radiation therapy on the body's muscles, organs, and bones in patients with stage III non-small cell lung cancer may help doctors plan the best treatment. PURPOSE: This clinical trial is studying the effects of radiation therapy on the body in patients with stage III non-small cell lung cancer.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Geographic Reach
1 country

1 active site

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 1, 2007

Completed
7 months until next milestone

First Submitted

Initial submission to the registry

September 13, 2007

Completed
4 days until next milestone

First Posted

Study publicly available on registry

September 17, 2007

Completed
Last Updated

July 14, 2011

Status Verified

July 1, 2011

First QC Date

September 13, 2007

Last Update Submit

July 13, 2011

Conditions

Keywords

weight changesmalnutritionstage III non-small cell lung cancer

Outcome Measures

Primary Outcomes (8)

  • Energy and protein consumption measured on an average radiotherapy treatment day by multiple pass method 24-hour analysis for food recall at baseline and treatment end

  • Comparison of energy and protein by mouth intake from baseline to treatment end

  • Comparison of diet quality as measured by Healthy Eating Index (HEI) score from baseline to treatment end

  • Lean body mass versus fat mass using a bioelectrical impedance analysis machine

  • Comparison of body fat to lean body mass percentage at baseline and at treatment end

  • Correlation of energy and protein consumption with lean body mass at baseline and treatment end

  • Change in appetite throughout radiotherapy determined by interview at baseline and end of treatment

  • Change in performance level (Karnofsky percentage) associated with the radiotherapy procedure determined by questions asked at baseline and end of treatment

Interventions

Eligibility Criteria

Age50 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Primary care center

You may qualify if:

  • Must be able to stand without assistance

You may not qualify if:

  • Unable to comply with study requirements
  • Native language other than American English
  • Pacemaker or implanted defibrillator
  • PRIOR CONCURRENT THERAPY:
  • Receiving chemotherapy in combination with radiotherapy
  • Concurrent megace or steroids

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ireland Cancer Center at University Hospitals Case Medical Center, Case Comprehensive Cancer Center

Cleveland, Ohio, 44106-5065, United States

Location

Related Links

MeSH Terms

Conditions

Lung NeoplasmsMalnutritionBody Weight ChangesCarcinoma, Non-Small-Cell Lung

Interventions

Radiotherapy

Condition Hierarchy (Ancestors)

Respiratory Tract NeoplasmsThoracic NeoplasmsNeoplasms by SiteNeoplasmsLung DiseasesRespiratory Tract DiseasesNutrition DisordersNutritional and Metabolic DiseasesBody WeightSigns and SymptomsPathological Conditions, Signs and SymptomsCarcinoma, BronchogenicBronchial Neoplasms

Intervention Hierarchy (Ancestors)

Therapeutics

Study Officials

  • Jessica Stauffer, BS

    Ireland Cancer Center at University Hospitals Case Medical Center, Case Comprehensive Cancer Center

    STUDY CHAIR
0

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER

Study Record Dates

First Submitted

September 13, 2007

First Posted

September 17, 2007

Study Start

February 1, 2007

Last Updated

July 14, 2011

Record last verified: 2011-07

Locations